Last Updated: 07 Nov 2024
Executive Summary
Definitive Healthcare Corp (DH) is a provider of healthcare data and analytics. The company's platform provides insights into the healthcare market, including data on hospitals, physicians, and other healthcare providers. DH has a strong financial position, with revenue growing by 0.046% year-over-year and EBITDA of $27.9 million. The company is currently trading at $4.3, below its analyst target price of $5.61.
Company Overview
DH was founded in 2000 and is headquartered in Framingham, Massachusetts. The company's platform provides data and analytics on the healthcare market, including information on hospitals, physicians, and other healthcare providers. DH's customers include pharmaceutical companies, medical device manufacturers, and healthcare providers.
Fundamental Analysis
DH has a strong financial position. The company's revenue has grown by 0.046% year-over-year to $258.47 million. DH's EBITDA is $27.9 million, and the company has a net loss of $3.5 million. The company's gross profit margin is 76.1%, and its operating margin is -0.0478%.
Technical Analysis
DH is currently trading at $4.3, below its 50-day moving average of $4.379 and its 200-day moving average of $6.1. The company's relative strength index (RSI) is 40.5, indicating that the stock is oversold.
Short Term Outlook
DH is expected to continue to grow in the short term. The company's revenue is expected to grow by 0.046% year-over-year in 2024. DH's earnings are expected to improve in the short term, as the company benefits from cost-cutting measures.
Long Term Outlook
DH is expected to continue to grow in the long term. The company's market is expected to grow as the healthcare industry continues to adopt data and analytics. DH is well-positioned to capitalize on this growth, as the company has a strong platform and a large customer base.
Analyst Recommendations
Analysts are bullish on DH. The consensus analyst rating is "Hold," and the average analyst target price is $5.61.
